These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11159513)

  • 1. A gene therapy approach for treating T-cell-mediated autoimmune diseases.
    Chen C; Rivera A; Ron N; Dougherty JP; Ron Y
    Blood; 2001 Feb; 97(4):886-94. PubMed ID: 11159513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
    Han D; Tian Y; Zhang M; Zhou Z; Lu J
    Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
    McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
    J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis.
    Ortega SB; Kashi VP; Tyler AF; Cunnusamy K; Mendoza JP; Karandikar NJ
    J Immunol; 2013 Jul; 191(1):117-26. PubMed ID: 23733879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK; Thomas DM
    J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
    J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
    Mohindru M; Kang B; Kim BS
    J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases.
    Melo ME; Qian J; El-Amine M; Agarwal RK; Soukhareva N; Kang Y; Scott DW
    J Immunol; 2002 May; 168(9):4788-95. PubMed ID: 11971030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
    J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.